NCT03347240 is a NA clinical trial of Brain Lesioning in Secondary Dystonia, sponsored by Ain Shams University.

Who is sponsoring NCT03347240?

NCT03347240 is sponsored by Ain Shams University.

What drugs are being tested in NCT03347240?

Interventions in NCT03347240: Brain Lesioning, Combined anterior and posterior lumbosacral rhizotomy, Deep brain stimulation, Intra-thecal baclofen infusion.

What condition does NCT03347240 study?

NCT03347240 studies Secondary Dystonia.

Is NCT03347240 still recruiting?

NCT03347240 is currently completed. Last updated 20 November 2017.

Last reviewed 2017-11-20 · How we verify

NCT03347240

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuroablation Versus Neuromodulation Techniques for Treatment of Secondary Dystonia

Completed NA Last updated 20 November 2017

What this trial tests

NA trial testing Brain Lesioning in Secondary Dystonia in 120 participants. Completed in 31 December 2016.

Timeline

1 December 2013

Primary endpoint
31 December 2016

31 December 2016

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	1 December 2013
Primary completion	31 December 2016
Estimated completion	31 December 2016

Drugs / interventions tested

Brain Lesioning
Combined anterior and posterior lumbosacral rhizotomy
Deep brain stimulation
Intra-thecal baclofen infusion

Conditions studied

Secondary Dystonia — all drugs for Secondary Dystonia →

Sponsor

Ain Shams University

Who can join

Adults 3 to 50, any sex, with Secondary Dystonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The disability inflected by dystonia encouraged the development of many neurosurgical procedures. This is a prospective study included 120 patients suffering from intractable secondary dystonia. They were subjected to different neurosurgical treatments and were assessed through the follow up period

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03347240 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 20 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03347240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing